As of 2026-03-22, the Relative Valuation of bluebird bio Inc (BLUE) is (418.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.97 USD, the upside of bluebird bio Inc based on Relative Valuation is -8525.7%.
The range of the Relative Valuation is (410.99) - (439.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.1x - 23.6x | 20.6x |
| Forward P/E multiples | 18.2x - 21.5x | 20.4x |
| Fair Price | (410.99) - (439.59) | (418.76) |
| Upside | -8369.5% - -8944.9% | -8525.7% |
| Date | P/E |